Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Results available

Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma

ClinicalTrials.gov ID: NCT02260492

Public ClinicalTrials.gov record NCT02260492. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 7:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a study to establish the equivalence of OT329 Solis and Advair Diskus when administered by inhalation in patients with asthma.

Study identification

NCT ID
NCT02260492
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Oriel Therapeutics
Industry
Enrollment
879 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2014 (Type not available)
Primary completion
May 2015 (Actual)
Completion
Jul 2015 (Actual)
Last update posted
Jun 15, 2017

2014 – 2015

United States locations

U.S. sites
47
U.S. states
22
U.S. cities
43
Facility City State ZIP Site status
Oriel Investigative Site Goodyear Arizona 85395 —
Oriel Investigative Site Tempe Arizona 85283 —
Oriel Investigative Site Anaheim California 92801 —
Oriel Investigative Site Los Angeles California 90017 —
Oriel Invetigative Site Los Angeles California 90048 —
Oriel Investigative Site Mission Viejo California 92691 —
Oriel Investigative Site Centennial Colorado 80112 —
Oriel Investigative Site Clearwater Florida 33756 —
Oriel Investigative Site Coral Gables Florida 33134 —
Oriel Investigative Site Homestead Florida 33030 —
Oriel Investigative Site Jupiter Florida 33458 —
Oriel Investigative Site Kissimee Florida 34741 —
Oriel Investigative Site Miami Florida 33165 —
Oriel Investigative Site New Port Richie Florida 34652 —
Oriel Investigative Site Orlando Florida 32806 —
Oriel Investigative Site Tallahassee Florida 32308 —
Oriel Investigative Site Lawrenceville Georgia 30046 —
Oriel Investigative Site Iowa City Iowa 52240 —
Oriel Investigative Site North Dartmouth Massachusetts 02747 —
Oriel Therapeutics Site Minneapolis Minnesota 55402 —
Oriel Investigative Site St Louis Missouri 63141 —
Oriel Investigative Site Bellevue Nebraska 68123 —
Oriel Investigative Site Omaha Nebraska 68114 —
Oriel Investigative Site Skillman New Jersey 08558 —
Oriel Investigative Site Albuquerque New Mexico 87108 —
Oriel Investigative Site New York New York 10018 —
Oriel Investigative Site Charlotte North Carolina 28277 —
Oriel Investigative Site Raleigh North Carolina 27607 —
Oriel Investigative Site Winston-Salem North Carolina 27103 —
Oriel Investigative Site Cincinnati Ohio 45231 —
Oriel Investigative Site Cincinnati Ohio 45242 —
Oriel Investigative Site Middleburg Heights Ohio 44130 —
Oriel Investigative Site Toledo Ohio 43617 —
Oriel Investigative Site Oklahoma City Oklahoma 73120 —
Oriel Investigative Site Eugene Oregon 97401 —
Oriel Investigative Site Medford Oregon 97504 —
Oriel Investigative Site Portland Oregon 97202 —
Oriel Investigative Site Providence Rhode Island 02906 —
Oriel Investigative Site Warwick Rhode Island 02886 —
Oriel Investigative Site Rock Hill South Carolina 29732 —
Oriel Investigative Site Austin Texas 78750 —
Oriel Investigative Site Austin Texas 78756 —
Oriel Investigative Site Houston Texas 77055 —
Oriel Investigative Site Houston Texas 77099 —
Oriel Investigative Site Plano Texas 75093 —
Oriel Investigative Site Richmond Virginia 23229 —
Oriel Investigative Site Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02260492, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 15, 2017 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02260492 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →